Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Plasma F2-isoprostane level and cognitive function over eight years in non-demented older adults: Findings from the Health ABC Study.

Fiocco AJ, Kanaya AM, Lindquist KM, Harris TB, Satterfield S, Simonsick EM, Kuller L, Rosano C, Yaffe K; Health ABC Study..

Prostaglandins Leukot Essent Fatty Acids. 2011 Jan-Feb;84(1-2):57-61. doi: 10.1016/j.plefa.2010.09.001.

2.

Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.

Ikizler TA, Morrow JD, Roberts LJ, Evanson JA, Becker B, Hakim RM, Shyr Y, Himmelfarb J.

Clin Nephrol. 2002 Sep;58(3):190-7.

PMID:
12356187
3.

Clinical factors associated with plasma F2-isoprostane levels in HIV-infected adults.

Redhage LA, Shintani A, Haas DW, Emeagwali N, Markovic M, Oboho I, Mwenya C, Erdem H, Acosta EP, Morrow JD, Hulgan T.

HIV Clin Trials. 2009 May-Jun;10(3):181-92. doi: 10.1310/hct1003-181.

4.

Plasma F2-isoprostane class VI isomers at 12-18 weeks of pregnancy are associated with later occurrence of preeclampsia.

Bilodeau JF, Qin Wei S, Larose J, Greffard K, Moisan V, Audibert F, Fraser WD, Julien P.

Free Radic Biol Med. 2015 Aug;85:282-7. doi: 10.1016/j.freeradbiomed.2015.05.012.

5.

Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself.

Dorjgochoo T, Gao YT, Chow WH, Shu XO, Yang G, Cai Q, Rothman N, Cai H, Li H, Deng X, Franke A, Roberts LJ, Milne G, Zheng W, Dai Q.

Am J Clin Nutr. 2012 Aug;96(2):405-14. doi: 10.3945/ajcn.112.034918.

6.

Aerobic training reduces systemic oxidative stress in young women with elevated levels of F2-isoprostanes.

Arikawa AY, Thomas W, Gross M, Smith A, Phipps WR, Kurzer MS, Schmitz KH.

Contemp Clin Trials. 2013 Mar;34(2):212-7. doi: 10.1016/j.cct.2012.11.003.

7.

Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry.

Davies SS, Zackert W, Luo Y, Cunningham CC, Frisard M, Roberts LJ 2nd.

Anal Biochem. 2006 Jan 15;348(2):185-91.

PMID:
16309621
8.

Increase in cerebrospinal fluid F2-isoprostanes is related to cognitive decline in APOE ε4 carriers.

Duits FH, Kester MI, Scheffer PG, Blankenstein MA, Scheltens P, Teunissen CE, van der Flier WM.

J Alzheimers Dis. 2013;36(3):563-70. doi: 10.3233/JAD-122227.

PMID:
23629585
9.
10.

Influence of lifestyle modifications on age-related free radical injury to brain.

Peskind ER, Li G, Shofer JB, Millard SP, Leverenz JB, Yu CE, Raskind MA, Quinn JF, Galasko DR, Montine TJ.

JAMA Neurol. 2014 Sep;71(9):1150-4. doi: 10.1001/jamaneurol.2014.1428.

11.

Increased urinary F2-isoprostanes in systemic sclerosis, but not in primary Raynaud's phenomenon: effect of cold exposure.

Cracowski JL, Carpentier PH, Imbert B, Cachot S, Stanke-Labesque F, Bessard J, Bessard G.

Arthritis Rheum. 2002 May;46(5):1319-23.

12.

Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha).

Dworski R, Roberts LJ 2nd, Murray JJ, Morrow JD, Hartert TV, Sheller JR.

Clin Exp Allergy. 2001 Mar;31(3):387-90.

PMID:
11260149
13.

Obesity, age, and oxidative stress in middle-aged and older women.

Dorjgochoo T, Gao YT, Chow WH, Shu XO, Yang G, Cai Q, Rothman N, Cai H, Li H, Deng X, Shrubsole MJ, Murff H, Milne G, Zheng W, Dai Q.

Antioxid Redox Signal. 2011 Jun 15;14(12):2453-60. doi: 10.1089/ars.2010.3337.

14.

Urinary biomarkers of oxidative stress and breast cancer survival.

Nechuta S, Cai Q, Zheng Y, Milne GL, Cai H, Dai Q, Yang G, Zheng W, Lu W, Shu XO.

Cancer Causes Control. 2014 Jun;25(6):701-7. doi: 10.1007/s10552-014-0373-7.

15.

[Longitudinal study of cognitive aging in non-demented elderly subjects].

Jacqmin-Gadda H, Fabrigoule C, Commenges D, Dartigues JF.

Rev Epidemiol Sante Publique. 1997 Oct;45(5):363-72. French.

PMID:
9446142
16.

Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease.

Irizarry MC, Yao Y, Hyman BT, Growdon JH, Praticò D.

Neurodegener Dis. 2007;4(6):403-5.

PMID:
17934322
17.

Serum 8,12-iso-iPF2α-VI isoprostane marker of oxidative damage and cognition deficits in children with konzo.

Makila-Mabe BG, Kikandau KJ, Sombo TM, Okitundu DL, Mwanza JC, Boivin MJ, Ngoyi MD, Muyembe JJ, Banea JP, Boss GR, Tshala-Katumbay D.

PLoS One. 2014 Sep 15;9(9):e107191. doi: 10.1371/journal.pone.0107191.

18.

F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome.

De Felice C, Signorini C, Durand T, Oger C, Guy A, Bultel-Poncé V, Galano JM, Ciccoli L, Leoncini S, D'Esposito M, Filosa S, Pecorelli A, Valacchi G, Hayek J.

J Lipid Res. 2011 Dec;52(12):2287-97. doi: 10.1194/jlr.P017798.

19.

Oxidant stress is increased during treatment of human immunodeficiency virus infection.

Hulgan T, Morrow J, D'Aquila RT, Raffanti S, Morgan M, Rebeiro P, Haas DW.

Clin Infect Dis. 2003 Dec 15;37(12):1711-7.

PMID:
14689356
20.

Key issues in F2-isoprostane analysis.

Nourooz-Zadeh J.

Biochem Soc Trans. 2008 Oct;36(Pt 5):1060-5. doi: 10.1042/BST0361060. Review.

PMID:
18793189

Supplemental Content

Support Center